These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37433968)

  • 1. Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protection.
    Cacace R; Zhou L; Hendrickx Van de Craen E; Buist A; Hoogmartens J; Sieben A; Cras P; Vandenberghe R; De Deyn PP; Oehlrich D; De Bondt A; Engelborghs S; Moechars D; Van Broeckhoven C
    Mol Psychiatry; 2023 Dec; 28(12):5380-5389. PubMed ID: 37433968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
    Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
    Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
    Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
    Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
    Butchi NB; Du M; Peterson KE
    Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate Immunity Fights Alzheimer's Disease.
    Guillot-Sestier MV; Doty KR; Town T
    Trends Neurosci; 2015 Nov; 38(11):674-681. PubMed ID: 26549882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of toll-like receptor signalling in Abeta uptake and clearance.
    Tahara K; Kim HD; Jin JJ; Maxwell JA; Li L; Fukuchi K
    Brain; 2006 Nov; 129(Pt 11):3006-19. PubMed ID: 16984903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease.
    Jin JJ; Kim HD; Maxwell JA; Li L; Fukuchi K
    J Neuroinflammation; 2008 May; 5():23. PubMed ID: 18510752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease.
    Fiala M; Cribbs DH; Rosenthal M; Bernard G
    J Alzheimers Dis; 2007 Jul; 11(4):457-63. PubMed ID: 17656824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis.
    Li X; Melief E; Postupna N; Montine KS; Keene CD; Montine TJ
    Am J Pathol; 2015 Jan; 185(1):230-9. PubMed ID: 25452117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.
    Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G
    J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia.
    Carroll JA; Race B; Williams K; Striebel JF; Chesebro B
    J Neuroinflammation; 2021 Sep; 18(1):194. PubMed ID: 34488805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
    Yang J; Wise L; Fukuchi KI
    Front Immunol; 2020; 11():724. PubMed ID: 32391019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-Like Receptor-9 (TLR9) is Requisite for Acute Inflammatory Response and Injury Following Lung Contusion.
    Suresh MV; Thomas B; Dolgachev VA; Sherman MA; Goldberg R; Johnson M; Chowdhury A; Machado-Aranda D; Raghavendran K
    Shock; 2016 Oct; 46(4):412-9. PubMed ID: 26939039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial Activation and Priming in Alzheimer's Disease: State of the Art and Future Perspectives.
    Bivona G; Iemmolo M; Agnello L; Lo Sasso B; Gambino CM; Giglio RV; Scazzone C; Ghersi G; Ciaccio M
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
    Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
    Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic Acid-Sensing Toll-Like Receptors Play a Dominant Role in Innate Immune Recognition of Pneumococci.
    Famà A; Midiri A; Mancuso G; Biondo C; Lentini G; Galbo R; Giardina MM; De Gaetano GV; Romeo L; Teti G; Beninati C
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209688
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    La Rosa F; Saresella M; Baglio F; Piancone F; Marventano I; Calabrese E; Nemni R; Ripamonti E; Cabinio M; Clerici M
    Sci Rep; 2017 Dec; 7(1):16760. PubMed ID: 29196629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.